CDXS Stock Discussion

Codexis, Inc. Description

Codexis, Inc. engages in the production of custom industrial enzymes for use in the pharmaceutical, biofuel, and chemical production. The company offers Codex Biocatalyst Panels and Kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. It also provides enzyme screening, enzyme optimization, and enzyme services, as well as supplies intermediates and active pharmaceutical ingredients to pharmaceutical companies. In addition, the company develops CodeXyme cellulase enzymes to convert cellulosic biomass, a non-food plant material into affordable sugars, which could then be converted into renewable fuels and chemicals; and CodeXol detergent alcohols used to manufacture surfactants, which are used as cleaning ingredients in consumer products, such as shampoos, liquid soaps, and laundry detergents. It intends to market CodeXyme cellulase enzymes to chemicals manufacturers; and CodeXol detergent alcohols as a drop-in substitute for the detergent alcohols market. The company has collaboration with Purolite Corporation to develop and market enzymes for the pharmaceutical industry. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Chemical Consumer Products Alcohol Telehealth Telemedicine Chemical Product Manufacturing Process Drug Development Biofuel Enzymes Detergent Shampoo Biomass Active Pharmaceutical Ingredients Cellulose Manufacturing Processes Surfactant Renewable Fuels Catalysis Laundry Detergent